Skip to Main Content
Welcome to theĀ Scientist.comĀ Marketplace

Go to Main Navigation

T39274

Lumasiran sodium

TargetMol

Thumbnail image

DETAILS

  • Purity: 98%
  • Category: Compounds
  • Cas Number: 1834612-06-4

DESCRIPTION

Lumasiran sodium, an investigational RNA interference (RNAi) therapeutic agent, reduces hepatic oxalate production by targeting glycolate oxidase . Lumasiran sodium reduces urinary oxalate excretion, the cause of progressive kidney failure in primary hyperoxaluria type 1 (PH1).

Lead Time: 4 - 5 weeks

Sign in to view pricing